Summit Therapeutics (SMMT) Change in Intangibles (2019 - 2020)
Summit Therapeutics (SMMT) reported Change in Intangibles of -$168000.0 for Q3 2020, down 4300.0% quarter-over-quarter from $4000.0 in Q2 2020.
Summit Therapeutics (SMMT) Change in Intangibles (2019 - 2020) Analysis & Trends
Summit Therapeutics has reported Change in Intangibles for 2 years, with the latest figure at -$168000.0 in Q3 2020.
- For the quarter ending Q3 2020, Change in Intangibles changed N/A year-over-year to -$168000.0; the trailing twelve-month figure through Jun 2021 stood at -$168000.0 (changed N/A YoY), and the FY2019 full-year result was $136000.0, changed N/A from the prior year.
- Change in Intangibles for Q3 2020 stood at -$168000.0, down from $4000.0 in the prior quarter.
- The five-year high for Change in Intangibles was $164000.0 in Q1 2020, with the low at -$168000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Summit Therapeutics | 10.09 Bn | 9.99 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -168,000.00 |
| Sep 30, 2020 | -168,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 164,000.00 |
| Mar 31, 2020 | 164,000.00 |
| Dec 31, 2019 | 25,000.00 |
| Dec 31, 2019 | 25,000.00 |